IMMUNOBIOLOGY LIMITED

Active Cambridge

Research and experimental development on biotechnology

3 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
I

IMMUNOBIOLOGY LIMITED

Research and experimental development on biotechnology

Founded 26 May 1999 Active Cambridge, United Kingdom 3 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 30 May 2025 Next due 28 Feb 2026 3 months overdue
Confirmation Submitted 28 Feb 2025 Next due 13 Mar 2026 2 months overdue
Net assets £-172K £39K 2024 year on year
Total assets £15K £39K 2024 year on year
Total Liabilities £186K £0 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Babraham Research Campus Babraham Cambridge CB22 3AT

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for IMMUNOBIOLOGY LIMITED (03777578), an active life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 26 May 1999. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2014–2024)

Cash in Bank

N/A

Decreased by £52.10k (-100%)

Net Assets

-£171.66k

Decreased by £39.23k (-30%)

Total Liabilities

£186.28k

Turnover

N/A

Employees

3

Debt Ratio

1274%

Increased by 928 (+268%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3

Investors (2)

Investor NameInvestor SinceParticipating Rounds
Investor 2Nov 2005Seed
Investor 3Oct 2012Unknown/Other

Share Capital

Share Capital

Share allotments and capital structure

11 Allotments 170,200,120 Shares £29429460.29m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
13 May 202513,999,999£2.10m£0.15
13 May 202513,999,999£2.10m£0.15
7 Feb 20207,500,000£150k£0.02
12 Mar 201920,100,000£201k£0.01
29 May 201866,000,000£330k£0.005

Officers

Officers

1 active 2 resigned
Status
Clarke, Graham JohnDirectorBritishEngland7022 Jan 2001Active

Shareholders

Shareholders (54)

British Smaller Companies Vct2 Plc
12.2%
26,700,000
Oxford Technology 2 Vct Plc
12.2%
26,700,000

Persons with Significant Control

Persons with Significant Control (2)

2 Active 1 Ceased
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Mark Robert Blandford

British

Active
Notified 12 Mar 2019
Residence United Kingdom
DOB November 1957
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Rockridge Investments, S.a

Ceased 6 Apr 2016

Ceased

Group Structure

Group Structure

IMMUNOBIOLOGY LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
28 Apr 2026GazetteGazette Notice Compulsory
11 Jun 2025CapitalAllotment of shares (GBP 3,076,534.657) on 13 May 2025
31 May 2025GazetteGazette Filings Brought Up To Date
30 May 2025AccountsAnnual accounts made up to 31 May 2024
27 May 2025CapitalAllotment of shares (GBP 3,076,534.657) on 13 May 2025
28 Apr 2026 Gazette

Gazette Notice Compulsory

11 Jun 2025 Capital

Allotment of shares (GBP 3,076,534.657) on 13 May 2025

31 May 2025 Gazette

Gazette Filings Brought Up To Date

30 May 2025 Accounts

Annual accounts made up to 31 May 2024

27 May 2025 Capital

Allotment of shares (GBP 3,076,534.657) on 13 May 2025

Recent Activity

Latest Activity

Gazette Notice Compulsory

1 weeks ago on 28 Apr 2026

Allotment of shares (GBP 3,076,534.657) on 13 May 2025

10 months ago on 11 Jun 2025

Gazette Filings Brought Up To Date

11 months ago on 31 May 2025

Annual accounts made up to 31 May 2024

11 months ago on 30 May 2025

Allotment of shares (GBP 3,076,534.657) on 13 May 2025

11 months ago on 27 May 2025